Myopia Control

SAN DIEGO — Diffusion Optics Technology spectacle lenses were safe and statistically significantly reduced axial length at 3 years in children who began treatment between ages 6 and 10 years, according to a study presented at Academy 2022.

SAN DIEGO — Data from a 7-year clinical study of the MiSight 1-Day myopia control lens indicated that the fastest progressing eyes slowed the most during treatment, as reported at a virtual press conference held during Academy 2022.

SAN DIEGO — Preliminary data from a 3-year, phase 3 clinical trial of Vyluma’s NVK002 supported its safety and efficacy as a potential treatment for myopia progression in children, according to a press release from the company.

LAS VEGAS – Every primary care optometrist can provide their pediatric patients with optimal visual function throughout their lives by offering myopia control, Valerie M. Kattouf, OD, told Healio at Vision Expo West.

Eyeglasses that use SightGlass Vision Diffusion Optic Technology significantly reduced axial length and cycloplegic spherical equivalent refraction progression in children aged 6 to 7 years with myopia, the company announced in a press release.

CHICAGO — An individualized protocol of combined treatments provided “remarkable” control of cycloplegic spherical equivalent refractive error and axial length in children over a 3-year period, according to a poster at Optometry’s Meeting.

CHICAGO – CooperVision announced at Optometry’s Meeting the availability of its MiSight 1 day contact lenses in higher prescriptions.

DENVER – Treatment gains resulting from CooperVision’s MiSight myopia control contact lenses were found to remain in children of all ages after they switched to single vision contact lenses, according to a study presented here at ARVO.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Robert T. Ang, MD, discusses his 8 years of real-world experience using small-aperture IOLs.

Johnson & Johnson Vision received approval from Health Canada for its Acuvue Abiliti 1-Day lenses for slowing myopia progression in children.